Search research articles
Contact Us
Filters
Showing results (111-120 of 201) with videos related to
Page
of 21
Sort By:
Cancer Research
|
March 1, 1985
Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro
L H Matherly, M K Voss, L A Anderson, et al.
Seminars in Oncology
|
July 26, 2002
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer
Lee F Allen, Peter F Lenehan, Irene A Eiseman, et al.
Molecular Pharmacology
|
August 1, 1993
Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity
D W Fry, T J Boritzki, R C Jackson, et al.
Journal of Medicinal Chemistry
|
March 28, 1997
Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases
J Singh, E M Dobrusin, D W Fry, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1996
Structure-activity relationships for 4-anilinoquinazolines as potent inhibitors at the ATP binding site of the epidermal growth factor receptor in vitro
W A Denny, G W Rewcastle, A J Bridges, et al.
Biochemical Pharmacology
|
November 1, 1988
Inhibition of type II topoisomerase by fostriecin
T J Boritzki, T S Wolfard, J A Besserer, et al.
Anticancer Research
|
June 16, 1999
Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors
Y Sun, D W Fry, P Vincent, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor
A M Thompson, A J Bridges, D W Fry, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor
G W Rewcastle, A J Bridges, D W Fry, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 19, 2005
Translation squared: improving asthma care for high-disparity populations through a safety net practice-based research network
Elvan C Daniels, Janice Bacon, Sandra Denisio, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 201) with videos related to
Sort By:
Page
of 21
Cancer Research
|
March 1, 1985
Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro
L H Matherly, M K Voss, L A Anderson, et al.
Seminars in Oncology
|
July 26, 2002
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer
Lee F Allen, Peter F Lenehan, Irene A Eiseman, et al.
Molecular Pharmacology
|
August 1, 1993
Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity
D W Fry, T J Boritzki, R C Jackson, et al.
Journal of Medicinal Chemistry
|
March 28, 1997
Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases
J Singh, E M Dobrusin, D W Fry, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1996
Structure-activity relationships for 4-anilinoquinazolines as potent inhibitors at the ATP binding site of the epidermal growth factor receptor in vitro
W A Denny, G W Rewcastle, A J Bridges, et al.
Biochemical Pharmacology
|
November 1, 1988
Inhibition of type II topoisomerase by fostriecin
T J Boritzki, T S Wolfard, J A Besserer, et al.
Anticancer Research
|
June 16, 1999
Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors
Y Sun, D W Fry, P Vincent, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor
A M Thompson, A J Bridges, D W Fry, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor
G W Rewcastle, A J Bridges, D W Fry, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 19, 2005
Translation squared: improving asthma care for high-disparity populations through a safety net practice-based research network
Elvan C Daniels, Janice Bacon, Sandra Denisio, et al.
Page
of 21